Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00054
|
|||||
Drug Name |
Quinine
|
|||||
Synonyms |
(+)-Quinidine; (-)-Quinine; (1R)-(6-Methoxyquinolin-4-yl)((1S,4S,5R)-5-vinylquinuclidin-2-yl)methanol; (3A,8A,9r)-6'-methoxycinchonan-9-ol; (5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; (8-alpha,9R)-6'-Methoxycinchonan-9-ol; (8.alpha.,9R)-6'-Methoxycinchonan-9-ol; (8S,9R)-6'-Methoxycinchonan-9-ol; (8S,9R)-Quinine; (9R)-6'-methoxy-8alpha-cinchonan-9-ol; (R)-(-)-Quinine, 6-methoxycinchonidine; (R)-(-)-quinine; (R)-(6-Methoxy-quinolin-4-yl)-((2S,5S)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol; (R)-(6-methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol; (R)-[(2S,4R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (R)-[(2S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (S)-(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; (S)-[(2R,4R,5S)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; 6'-Methoxycinchonan-9-ol; 6'-Methoxycinchonidine; 6'-Methoxycinchonine; 6-Methoxycinchonine; Aflukin; Alpha-(6-Methoxy-4-quinoyl)-5-vinyl-2-quinclidinemethanol; Beta-Quinine; Biquinate (*Bisulfate heptathydrate*); Chinin; Chinin [German]; Chinine; Chininum; Cin-Quin; Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)-, sulfate; Coco-Quinine; Conchinin; Conquinine; Dentojel (*Bisulfate heptathydrate*); IBS-L0034250; Kinder Quinina; Kinder Quinina (TN); LT00645788;Q0028; Legatrin (TN); QUININE MONO HCL; Quinamm (*2:1 Sulfate salt*), dihydrate; Quindan; Quine (*2:1 Sulfate salt*, dihydrate); Quinidex; Quinidine; Quinimax; Quinina; Quinine (BAN); Quinine Dab; Quinine [BAN]; Quinine anhydrous; Quinine bisulfate; Quinine sulfate; Quinine sulphate; Quinine, Anhydrous; Quinine, polymers; Quinine, tannate; Quinineanhydrous; Quinoline alkaloid; Quinora; Quinsan (*2:1 Sulfate salt*), dihydrate; Quniacridine; SB01652
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Malaria [ICD11: 1F40] | Approved | [1] | |||
Therapeutic Class |
Antimalarials
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C20H24N2O2
|
|||||
Canonical SMILES |
COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O
|
|||||
InChI |
InChI=1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3/t13-,14-,19-,20+/m0/s1
|
|||||
InChIKey |
LOUPRKONTZGTKE-WZBLMQSHSA-N
|
|||||
CAS Number |
CAS 130-95-0
|
|||||
Pharmaceutical Properties | Molecular Weight | 324.4 | Topological Polar Surface Area | 45.6 | ||
Heavy Atom Count | 24 | Rotatable Bond Count | 4 | |||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 4 | |||
XLogP |
2.9
|
|||||
PubChem CID | ||||||
PubChem SID |
10047893
, 103401549
, 104014717
, 104179003
, 111635622
, 117498515
, 126609105
, 127305362
, 127305363
, 127305364
, 127305365
, 127305366
, 127305367
, 127305368
, 127305369
, 127305370
, 128520104
, 128520105
, 134973208
, 135231014
, 135652709
, 136076620
, 136202233
, 136904085
, 137019039
, 137224223
, 139072192
, 142847474
, 14797229
, 152164544
, 152248148
, 160846349
, 162178599
, 162202314
, 162224671
, 29204524
, 44424807
, 46507493
, 49681219
, 50077764
, 56480783
, 57309160
, 598422
, 7980452
, 80217992
, 8145105
, 83100521
, 87623901
, 92308761
, 92310322
|
|||||
ChEBI ID |
ChEBI:15854
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | BGT1 | Transporter Info | Na(+)/Cl(-) betaine/GABA transporter | Substrate | [2] | |
OCT-1 | Transporter Info | Organic cation transporter 1 | Substrate | [3] | ||
OCT-2 | Transporter Info | Organic cation transporter 2 | Substrate | [4] | ||
OCTN1 | Transporter Info | Organic cation/carnitine transporter 1 | Substrate | [5] | ||
OCTN2 | Transporter Info | Organic cation/carnitine transporter 2 | Substrate | [6] | ||
P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [7] | ||
Drug-Transporter Activity Data | ||||||
Drug-Transporter Activity Data | OCT-2 | Transporter Info | Km = 2.6 microM | Oocytes-OCT2 | [4] | |
P-GP | Transporter Info | Km = 10 microM | Chinese hamster ovary AA8 cells-MDR1 | [8] | ||
P-GP | Transporter Info | Km = 5.42 microM | High five cells-MDR1 | [9] | ||
References | ||||||
1 | Quinine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | The Transporter Classification Database (TCDB): recent advances. Nucleic Acids Res. 2016 Jan 4;44(D1):D372-9. (ID: 2.A.22.3.1) | |||||
3 | Comparison of type I and type II organic cation transport by organic cation transporters and organic anion-transporting polypeptides. J Pharmacol Exp Ther. 2001 Jul;298(1):110-5. | |||||
4 | Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol. 1997 Jul;16(7):871-81. | |||||
5 | Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J Pharmacol Exp Ther. 1999 May;289(2):768-73. | |||||
6 | Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J Pharmacol Exp Ther. 1999 Nov;291(2):778-84. | |||||
7 | Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64. | |||||
8 | Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity. J Biol Chem. 1996 Feb 9;271(6):3163-71. | |||||
9 | Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein. Pharm Res. 2001 Dec;18(12):1660-8. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.